Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retrospective Study Evaluating the Effectiveness and Safety of Immunotherapy With Clustoid®/Clustek®/Alxoid® for the Treatment of Dermatophagoides/Blomia Tropicalis Allergy in Real-Life Conditions

NCT07427576 is registered in ClinicalTrials.gov with Inmunotek S.L. as lead sponsor.

NCT NCT07427576
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07427576 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retrospective Study Evaluating the Effectiveness and Safety of Immunotherapy With Clustoid®/Clustek®/Alxoid® for the Treatment of Dermatophagoides/Blomia Tropicalis Allergy in Real-Life Conditions
Lead sponsor
Inmunotek S.L.
Phase
Observational
Overall status
Completed
Start date
March 31, 2025
Completion date
December 31, 2025
Enrollment
140 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

asthma, dermatophagoides farinae allergy, dermatophagoides pteronyssinus allergy, mite allergy, rhinitis, allergic, rhinoconjunctivitis